Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Primary objective of the study is to determine the extent that offering of self-sampling in addition to clinician-sampling Human Papillomavirus (HPV) DNA testing will increase detection of HPV DNA through an increase in uptake rates of cervical cancer screening as compared to offering clinician-sampling HPV DNA testing alone. The hypothesis is that offering additional self-sampling will increase the detection of high-risk HPV DNA by at least 7.7%.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 30
Maximum Age: 69
Healthy Volunteers: t
View:
• 30-69 years old female Singapore citizens
• Due for cervical cancer screening
• Engaged in sexual intercourse before
• Able to give informed consent
• Able to read and communicate in English, Chinese or Malay
Locations
Other Locations
Singapore
National Healthcare Group Polyclinics
RECRUITING
Singapore
Contact Information
Primary
Ng Xin Rong, MBBS
xin_rong_ng@nhgp.com.sg
+65 63553000
Time Frame
Start Date: 2024-08-05
Estimated Completion Date: 2026-12
Participants
Target number of participants: 650
Treatments
Active_comparator: Usual care arm
Participants will only be offered clinician-sampling for HPV DNA testing to determine if they are agreeable to undergo screening.
Experimental: Intervention arm
Participants will be offered clinician-sampling or self-sampling for HPV DNA testing to determine if they are agreeable to undergo screening using either modality.
Related Therapeutic Areas
Sponsors
Collaborators: KK Women's and Children's Hospital, National Healthcare Group, Singapore
Leads: National Healthcare Group Polyclinics